Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy

Vascular and Endovascular Surgery

Volumn 38, Issue 4, 2004, Pages 345-348

  Samson, Russell H ^a,b   Yungst, Zachary ^a,b   Showalter, David P ^a,b  

^a Mote Vascular Foundation ^*

^b Mote Vascular Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FOLIC ACID; HOMOCYSTEINE; MULTIVITAMIN;

AGED; AMINO ACID BLOOD LEVEL; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; ECHOGRAPHY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RESTENOSIS; TREATMENT OUTCOME;

AGED; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CHI-SQUARE DISTRIBUTION; ENDARTERECTOMY, CAROTID; FEMALE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; RECURRENCE; RISK FACTORS;

EID: 4043178567     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440403800406     Document Type: Article

References (16)

1. 6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97:437-443, 1998.
2. McCully KS: Homocysteine and vascular disease. Nat Med 2:386-389, 1996.
3. Christen WG, Ajani UA, Glynn RJ, et al: Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 160:422-434, 2000.
4. Eikelboom JW, Lonn E, Genest J Jr, et al: Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 131:363-375, 1999.
5. Selhub J, Jacques PF, Bostom AG, et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286-291, 1995.
6. Franken DG, Boers GH, Blom HJ, et al: Treatment of mild hyperhomocyst(e)inemia in vascular disease patients. Arterioscler Thromb 14:465-470, 1994.
7. Morita H, Kurihara H, Yoshida S, et al: Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103:133-139, 2001.
8. Samson RH, Showalter DP, Yunis JP, et al: Hemodynamically significant early recurrent carotid stenosis: An often self-limiting and self-reversing condition. J Vasc Surg 30:446-452, 1999.
9. Stampfer MJ, Malinow MR, Willett WC, et al: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992.
10. Al-Obaidi MK, Philippou H, Stubbs PJ, et al: Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation 101:372-377, 2000.
11. Mansoor MA, Bergmark C, Svardal AM, et al: Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 15:232-240, 1995.
12. Woo KS, Chook P, Lolin YI, et al: Hyperhomocyst(e)inemia is a risk factor for endothelial dysfunction in humans. Circulation 96:2542-2544, 1997.
13. Tawakol A, Omland T, Gerhard M, et al: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119-1121, 1997.
14. Schnyder G, Roffi M, Flammer Y, et al: Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries. Am J Cardiol 91:1265-1269, 2003.
15. Wald DS, Bishop L, Wald NJ, et al: Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 161:695-700, 2001.
16. Appel LJ, Miller ER III, Jee SH, et al: Effect of dietary patterns on serum homocysteine: Results of a randomized, controlled feeding study. Circulation 102: 852-857, 2000.